Showing results (31-40 of 123) with videos related to
Sort By:
Pageof 13
The Medical Clinics of North America|September 12, 2006
Mood disorders in the elderlyMehret Gebretsadik, Sundeep Jayaprabhu, George T GrossbergTherapeutic Advances in Drug Safety|March 2, 2018
An update on the safety of current therapies for Alzheimer's disease: focus on rivastigmineRita Khoury, Jayashree Rajamanickam, George T GrossbergExpert Opinion on Emerging Drugs|March 4, 2017
Emerging chemical therapies targeting 5-hydroxytryptamine in the treatment of Alzheimer's diseaseAmanda Calhoun, Je Ko, George T GrossbergAnnals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|October 26, 2017
Renal concerns relative to the use of lithium in geriatric bipolar disorder patientsJakub Szpunar, Hitoshi Maeshima, George T GrossbergAnnals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|October 30, 2020
Doll therapy in dementia: Facts and controversiesKala Chinnaswamy, Dominic M DeMarco, George T GrossbergExpert Opinion on Pharmacotherapy|April 21, 2026
Pharmacotherapeutic landscape for the management of agitation associated with Alzheimer's diseaseSamir Jain, Ece Buyuksandalyaci Tunc, George T GrossbergDrugs & Aging|June 3, 2015
The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's DiseaseWilliam James Deardorff, Eliahu Feen, George T GrossbergCurrent Psychiatry Reports|May 31, 2012
Behavioral disturbance in dementiaAbhilash K Desai, Lori Schwartz, George T GrossbergJournal of Clinical Pharmacology|July 1, 2006
Rationale for combination therapy with galantamine and memantine in Alzheimer's diseaseGeorge T Grossberg, Keith R Edwards, Qinying ZhaoExpert Review of Neurotherapeutics|December 16, 2014
Safety and clinical effects of EVP-6124 in subjects with Alzheimer's disease currently or previously receiving an acetylcholinesterase inhibitor medicationWilliam James Deardorff, Ahmad Shobassy, George T GrossbergPageof 13